With recent evidence of YAP/TAZ role in NB tumorigenicity, metastatic progression, treatment resistance and tumor relapse13,14,17,18,52, we aimed to investigate whether VPF can also be used as a potential therapeutic agent against NB. The gene discussed is VEGFA; the disease is neuroblastoma.